关键词：肺癌；非小细胞肺癌；吸烟；导致肺癌
摘 要：Lung cancer is a common cause of mortality and morbidity in both developed and developing countries. Non-small cell lung cancer is a common type of lung cancer and constitutes 85%-90% of the total diagnosed cases. Smoking is considered as the major cause of lung cancer, although lung cancer also occurs in non-smokers. Non-small cell lung cancer is categorized into three types: adenocarcinoma, squamous cell (epidermoid) carcinoma, and large cell (undifferentiated) carcinoma. Few of the commonly observed symptoms include chest pain, coughing up blood, chronic cough, fatigue, loss of appetite, weight loss, shortness of breath, and wheezing. Non-small cell lung cancer is recurrent in nature and difficult to cure.
目 录：

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Product profiles

PART 05: Introduction

Key market highlights

PART 06: Disease overview

Understanding the disease

Risk factors

Signs and symptoms

Diagnosis

Staging

Treatment

Epidemiology

PART 07: Pipeline portfolio

Information on pipeline candidates

PART 08: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 09: Market segmentation by molecule type

Biologics

Small molecules

PART 10: Market segmentation by route of administration

Oral

Parenteral

PART 11: Geographical segmentation

PART 12: Market drivers

PART 13: Impact of drivers

PART 14: Market challenges

PART 15: Impact of drivers and challenges

PART 16: Market trends

PART 17: Vendor landscape

Competitive scenario

Market analysis 2014

Other prominent vendors

PART 18: Key vendor analysis

AstraZeneca

Celgene

Eli Lilly

F. Hoffmann-La Roche

Pfizer

PART 19: Appendix

List of abbreviations

PART 20: Explore Technavio